Ocular Therapeutix (OCUL) Asset Utilization Ratio (2014 - 2026)

Ocular Therapeutix's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 51.08% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (down 51.08% YoY), while the FY2025 annual figure was 0.08, down 54.28% from the prior year.
• Asset Utilization Ratio was 0.07 for Q1 2026 at Ocular Therapeutix, down from 0.09 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q2 2023 to a low of 0.07 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.22 across 5 years, with a median of 0.15 in 2024.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio jumped 186.87% in 2022, then plunged 73.39% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2022, then dropped by 15.69% to 0.28 in 2023, then slumped by 52.35% to 0.13 in 2024, then plunged by 36.57% to 0.09 in 2025, then slipped by 20.75% to 0.07 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.07 (Q1 2026), 0.09 (Q4 2025), and 0.13 (Q3 2025), per Business Quant data.